speb/financial-data huggingface dataset:
CBAT balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -2841728.00
CBAT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 5402360.00
CBAT balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 16485019.00
CBAT income_statement (annual, 2024-12-31) — Basic Average Shares: 89928357.00
CBAT income_statement (annual, 2024-12-31) — Basic EPS: 0.13
CBAT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 58822816.00
CBAT balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 44590499.00
CBAT cash_flow (annual, 2024-12-31) — Capital Expenditure: -17186872.00
CBAT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3717461.00
CBAT balance_sheet (annual, 2024-12-31) — Capital Stock: 90083.00
CBAT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 6724360.00
CBAT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 10961450.00
CBAT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -11686513.00
CBAT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -23432205.00
CBAT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 39704460.00
CBAT cash_flow (annual, 2024-12-31) — Change In Account Payable: 4648150.00
CBAT cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 23749383.00
CBAT cash_flow (annual, 2024-12-31) — Change In Inventory: 6295598.00
CBAT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -2433194.00
CBAT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 61379.00
CBAT cash_flow (annual, 2024-12-31) — Change In Payable: 4648150.00
CBAT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 28397533.00
CBAT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -12462243.00
CBAT cash_flow (annual, 2024-12-31) — Change In Receivables: -4826714.00
CBAT cash_flow (annual, 2024-12-31) — Change In Working Capital: 15032359.00
CBAT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -5376670.00
CBAT cash_flow (annual, 2024-12-31) — Changes In Cash: 4585742.00
CBAT balance_sheet (annual, 2024-12-31) — Common Stock: 90083.00
CBAT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 121673043.00
CBAT cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
CBAT balance_sheet (annual, 2024-12-31) — Construction In Progress: 42526859.00
CBAT income_statement (annual, 2024-12-31) — Cost Of Revenue: 134839364.00
CBAT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 9592466.00
CBAT balance_sheet (annual, 2024-12-31) — Current Assets: 141396860.00
CBAT balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1268405.00
CBAT balance_sheet (annual, 2024-12-31) — Current Debt: 26423065.00
CBAT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 27691470.00
CBAT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 12244125.00
CBAT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 12244125.00
CBAT balance_sheet (annual, 2024-12-31) — Current Liabilities: 171700980.00
CBAT balance_sheet (annual, 2024-12-31) — Current Provisions: 23426.00
CBAT cash_flow (annual, 2024-12-31) — Depreciation: 9170788.00
CBAT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 9170788.00
CBAT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 9170788.00
CBAT income_statement (annual, 2024-12-31) — Diluted Average Shares: 90158312.00
CBAT income_statement (annual, 2024-12-31) — Diluted EPS: 0.13
CBAT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 11790032.00
CBAT balance_sheet (annual, 2024-12-31) — Dividends Payable: 1221915.00
CBAT income_statement (annual, 2024-12-31) — EBIT: 9619548.00
CBAT income_statement (annual, 2024-12-31) — EBITDA: 18790336.00
CBAT income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -18777.00
CBAT cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 18777.00
CBAT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2622556.00
CBAT cash_flow (annual, 2024-12-31) — End Cash Position: 60786002.00
CBAT cash_flow (annual, 2024-12-31) — Financing Cash Flow: -11686513.00
CBAT balance_sheet (annual, 2024-12-31) — Finished Goods: 14278530.00
CBAT cash_flow (annual, 2024-12-31) — Free Cash Flow: 22517588.00
CBAT cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -45749.00
CBAT cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: -18782.00
CBAT cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 428308.00
CBAT income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 45749.00
CBAT income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 18782.00
CBAT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -13688834.00
CBAT income_statement (annual, 2024-12-31) — General And Administrative Expense: 13947727.00
CBAT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 11458935.00
CBAT balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 28569823.00
CBAT balance_sheet (annual, 2024-12-31) — Gross PPE: 185720688.00
CBAT income_statement (annual, 2024-12-31) — Gross Profit: 41775245.00
CBAT income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 475220.00
CBAT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 2189247.00
CBAT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 408028.00
CBAT balance_sheet (annual, 2024-12-31) — Interest Payable: 69927.00
CBAT balance_sheet (annual, 2024-12-31) — Inventory: 22851027.00
CBAT balance_sheet (annual, 2024-12-31) — Invested Capital: 148096108.00
CBAT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -23432205.00
CBAT balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 16485019.00
CBAT balance_sheet (annual, 2024-12-31) — Investments And Advances: 18110812.00
CBAT cash_flow (annual, 2024-12-31) — Issuance Of Debt: 47507961.00
CBAT balance_sheet (annual, 2024-12-31) — Leases: 8058360.00
CBAT balance_sheet (annual, 2024-12-31) — Line Of Credit: 26087350.00
CBAT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2449056.00
CBAT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2449056.00
CBAT cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1112455.00
CBAT cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2814095.00
CBAT balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 1625793.00
CBAT balance_sheet (annual, 2024-12-31) — Long Term Provisions: 420688.00
CBAT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 87307121.00
CBAT balance_sheet (annual, 2024-12-31) — Minority Interest: -1605878.00
CBAT income_statement (annual, 2024-12-31) — Minority Interests: 2204882.00
CBAT cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 278114.00
CBAT cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 50.00
CBAT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CBAT balance_sheet (annual, 2024-12-31) — Net Debt: 19698705.00
CBAT income_statement (annual, 2024-12-31) — Net Income: 11790032.00
CBAT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 11790032.00
CBAT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 9585150.00
CBAT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 11790032.00
CBAT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 11790032.00
CBAT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 9585150.00
CBAT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 9585150.00
CBAT income_statement (annual, 2024-12-31) — Net Interest Income: 1283090.00
CBAT cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -9094322.00
CBAT cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: -1643.00
CBAT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -7385730.00
CBAT cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -1701640.00
CBAT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1283090.00
CBAT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -4300783.00
CBAT cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 9152871.00
CBAT cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 2355555.00
CBAT balance_sheet (annual, 2024-12-31) — Net PPE: 131251537.00
CBAT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -16971552.00
CBAT cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -5684090.00
CBAT cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 1386510.00
CBAT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 110214108.00
CBAT balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 7580255.00
CBAT balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 7580255.00
CBAT income_statement (annual, 2024-12-31) — Normalized EBITDA: 19575986.00
CBAT income_statement (annual, 2024-12-31) — Normalized Income: 12465797.73
CBAT balance_sheet (annual, 2024-12-31) — Notes Receivable: 7210823.00
CBAT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 39704460.00
CBAT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 401336.00
CBAT income_statement (annual, 2024-12-31) — Operating Income: 9619548.00
CBAT income_statement (annual, 2024-12-31) — Operating Revenue: 176614609.00
CBAT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 89939190.00
CBAT balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 335715.00
CBAT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -13688834.00
CBAT balance_sheet (annual, 2024-12-31) — Other Equity Interest: 14101689.00
CBAT income_statement (annual, 2024-12-31) — Other Gand A: 13947727.00
CBAT income_statement (annual, 2024-12-31) — Other Income Expense: 241125.00
CBAT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 11458935.00
CBAT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1045552.00
CBAT balance_sheet (annual, 2024-12-31) — Other Payable: 93434927.00
CBAT balance_sheet (annual, 2024-12-31) — Other Properties: 3237849.00
CBAT balance_sheet (annual, 2024-12-31) — Other Receivables: 9116377.00
CBAT balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 4237090.00
CBAT balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 4237090.00
CBAT balance_sheet (annual, 2024-12-31) — Payables: 122149493.00
CBAT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 131741959.00
CBAT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 8653740.00
CBAT income_statement (annual, 2024-12-31) — Pretax Income: 11143763.00
CBAT balance_sheet (annual, 2024-12-31) — Properties: 0.00
CBAT income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 356179.00
CBAT income_statement (quarterly, 2024-12-31) — Provision For Doubtful Accounts: 597511.00
CBAT cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -264181.00
CBAT cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CBAT cash_flow (annual, 2024-12-31) — Purchase Of Investment: -9094322.00
CBAT cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -1643.00
CBAT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -17186872.00
CBAT balance_sheet (annual, 2024-12-31) — Raw Materials: 3538167.00
CBAT balance_sheet (annual, 2024-12-31) — Receivables: 44869001.00
CBAT balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -289993.00
CBAT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 134839364.00
CBAT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 9170788.00
CBAT cash_flow (annual, 2024-12-31) — Repayment Of Debt: -54893691.00
CBAT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CBAT income_statement (annual, 2024-12-31) — Research And Development: 13010082.00
CBAT balance_sheet (annual, 2024-12-31) — Restricted Cash: 54061642.00
CBAT balance_sheet (annual, 2024-12-31) — Retained Earnings: -122605730.00
CBAT cash_flow (annual, 2024-12-31) — Sale Of Business: 278114.00
CBAT cash_flow (quarterly, 2024-12-31) — Sale Of Business: 50.00
CBAT cash_flow (annual, 2024-12-31) — Sale Of PPE: 215320.00
CBAT cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 30765.00
CBAT income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 5197888.00
CBAT income_statement (annual, 2024-12-31) — Selling General And Administration: 19145615.00
CBAT balance_sheet (annual, 2024-12-31) — Share Issued: 90083396.00
CBAT cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 46395506.00
CBAT cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 5531006.00
CBAT cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -52079596.00
CBAT cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: -4144496.00
CBAT income_statement (annual, 2024-12-31) — Special Income Charges: -785650.00
CBAT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 376648.00
CBAT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 121673043.00
CBAT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 110214108.00
CBAT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -109884.27
CBAT income_statement (annual, 2024-12-31) — Tax Provision: 1558613.00
CBAT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.14
CBAT balance_sheet (annual, 2024-12-31) — Taxes Receivable: 3011184.00
CBAT balance_sheet (annual, 2024-12-31) — Total Assets: 302218144.00
CBAT balance_sheet (annual, 2024-12-31) — Total Capitalization: 121673043.00
CBAT balance_sheet (annual, 2024-12-31) — Total Debt: 30140526.00
CBAT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 120067165.00
CBAT income_statement (annual, 2024-12-31) — Total Expenses: 166995061.00
CBAT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 182150979.00
CBAT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 160821284.00
CBAT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 10449999.00
CBAT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 8788149.00
CBAT income_statement (annual, 2024-12-31) — Total Other Finance Cost: -1283090.00
CBAT balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1175339.00
CBAT income_statement (annual, 2024-12-31) — Total Unusual Items: -785650.00
CBAT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -785650.00
CBAT balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 144206.00
CBAT balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 144206.00
CBAT balance_sheet (annual, 2024-12-31) — Treasury Stock: 4066610.00
CBAT balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 4066610.00
CBAT balance_sheet (annual, 2024-12-31) — Work In Process: 5034330.00
CBAT balance_sheet (annual, 2024-12-31) — Working Capital: -30304120.00
CBAT income_statement (annual, 2024-12-31) — Write Off: 356179.00
CBAT income_statement (quarterly, 2024-12-31) — Write Off: 597511.00
CBAT income_statement (quarterly, 2025-03-31) — +Operating Expense: 7724148.00
CBAT income_statement (quarterly, 2025-03-31) — +Total Revenue: 34938901.00
CBAT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 35298012.00
CBAT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 26150567.00
CBAT balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 202311.00
CBAT balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -54162506.00
CBAT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 247869511.00
CBAT balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -2577221.00
CBAT cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 934424.00
CBAT balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 16573114.00
CBAT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 89938690.00
CBAT income_statement (quarterly, 2025-03-31) — Basic EPS: -0.02
CBAT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 60786002.00
CBAT balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 44850015.00
CBAT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -12689383.00
CBAT balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3557232.00
CBAT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 90083.00
CBAT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4052010.00
CBAT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 9582040.00
CBAT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 5925771.00
CBAT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -9902768.00
CBAT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -9621121.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 8206996.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -4441468.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Inventory: -8748990.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -124846.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 3447.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Payable: 8206996.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 3765528.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1987955.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Receivables: -7717786.00
CBAT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -10834692.00
CBAT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -7717786.00
CBAT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -13598118.00
CBAT balance_sheet (quarterly, 2025-03-31) — Common Stock: 90083.00
CBAT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 120791786.00
CBAT balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 51527443.00
CBAT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 30137167.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 9249461.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Assets: 143158930.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1159373.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Debt: 29637533.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 30796906.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 14566515.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 14566515.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 175501624.00
CBAT balance_sheet (quarterly, 2025-03-31) — Current Provisions: 23000.00
CBAT cash_flow (quarterly, 2025-03-31) — Depreciation: 2416583.00
CBAT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2416583.00
CBAT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2416583.00
CBAT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 89938690.00
CBAT income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.02
CBAT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1579234.00
CBAT balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1228445.00
CBAT income_statement (quarterly, 2025-03-31) — EBIT: -2922414.00
CBAT income_statement (quarterly, 2025-03-31) — EBITDA: -505831.00
CBAT income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 55125.00
CBAT cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -55125.00
CBAT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 346819.00
CBAT cash_flow (quarterly, 2025-03-31) — End Cash Position: 47534703.00
CBAT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 5925771.00
CBAT balance_sheet (quarterly, 2025-03-31) — Finished Goods: 15854112.00
CBAT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -22310504.00
CBAT cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
CBAT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -11205832.00
CBAT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3804137.00
CBAT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 11325113.00
CBAT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 28727788.00
CBAT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 192880284.00
CBAT income_statement (quarterly, 2025-03-31) — Gross Profit: 4801734.00
CBAT cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
CBAT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 155212.00
CBAT balance_sheet (quarterly, 2025-03-31) — Interest Payable: 74095.00
CBAT balance_sheet (quarterly, 2025-03-31) — Inventory: 30803486.00
CBAT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 154561209.00
CBAT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -9902768.00
CBAT balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 16573114.00
CBAT balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 18262820.00
CBAT cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 24337737.00
CBAT balance_sheet (quarterly, 2025-03-31) — Leases: 8234169.00
CBAT balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 29301628.00
CBAT balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2397859.00
CBAT balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4131890.00
CBAT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 6529749.00
CBAT cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 24337737.00
CBAT cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -17143957.00
CBAT balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1689706.00
CBAT balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 417565.00
CBAT balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 85362005.00
CBAT balance_sheet (quarterly, 2025-03-31) — Minority Interest: -2048693.00
CBAT income_statement (quarterly, 2025-03-31) — Minority Interests: 471748.00
CBAT balance_sheet (quarterly, 2025-03-31) — Net Debt: 29717413.00
CBAT income_statement (quarterly, 2025-03-31) — Net Income: -1579234.00
CBAT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1579234.00
CBAT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2050982.00
CBAT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1579234.00
CBAT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1579234.00
CBAT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2050982.00
CBAT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2050982.00
CBAT income_statement (quarterly, 2025-03-31) — Net Interest Income: 45120.00
CBAT cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CBAT cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 7193780.00
CBAT cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 7193780.00
CBAT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 45120.00
CBAT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1268009.00
CBAT cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 2786615.00
CBAT balance_sheet (quarterly, 2025-03-31) — Net PPE: 138717778.00
CBAT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -12689383.00
CBAT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 109466673.00
CBAT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 10272610.00
CBAT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 10272610.00
CBAT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -564226.00
CBAT income_statement (quarterly, 2025-03-31) — Normalized Income: -1637629.00
CBAT balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 14684526.00
CBAT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -9621121.00
CBAT cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -55125.00
CBAT income_statement (quarterly, 2025-03-31) — Operating Income: -2922414.00
CBAT income_statement (quarterly, 2025-03-31) — Operating Revenue: 34938901.00
CBAT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 89939662.00
CBAT balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 335905.00
CBAT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -11205832.00
CBAT balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 14101689.00
CBAT income_statement (quarterly, 2025-03-31) — Other Gand A: 3804137.00
CBAT income_statement (quarterly, 2025-03-31) — Other Income Expense: 826312.00
CBAT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 11325113.00
CBAT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 712792.00
CBAT balance_sheet (quarterly, 2025-03-31) — Other Payable: 83508077.00
CBAT balance_sheet (quarterly, 2025-03-31) — Other Properties: 2906652.00
CBAT balance_sheet (quarterly, 2025-03-31) — Other Receivables: 7585299.00
CBAT balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 5530030.00
CBAT balance_sheet (quarterly, 2025-03-31) — Payables: 120865742.00
CBAT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 130115203.00
CBAT balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 7535521.00
CBAT income_statement (quarterly, 2025-03-31) — Pretax Income: -2050982.00
CBAT balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CBAT cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -58395.00
CBAT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CBAT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -12689383.00
CBAT balance_sheet (quarterly, 2025-03-31) — Raw Materials: 6536801.00
CBAT balance_sheet (quarterly, 2025-03-31) — Receivables: 51755190.00
CBAT balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -221445.00
CBAT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 30137167.00
CBAT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2416583.00
CBAT cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -17143957.00
CBAT income_statement (quarterly, 2025-03-31) — Research And Development: 3023961.00
CBAT balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 43482693.00
CBAT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -125997055.00
CBAT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 896050.00
CBAT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4700187.00
CBAT balance_sheet (quarterly, 2025-03-31) — Share Issued: 90083868.00
CBAT income_statement (quarterly, 2025-03-31) — Special Income Charges: 58395.00
CBAT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 27066.00
CBAT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 120791786.00
CBAT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 109466673.00
CBAT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CBAT income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
CBAT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CBAT balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 3353932.00
CBAT balance_sheet (quarterly, 2025-03-31) — Total Assets: 311464641.00
CBAT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 124923676.00
CBAT balance_sheet (quarterly, 2025-03-31) — Total Debt: 37326655.00
CBAT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 118743093.00
CBAT income_statement (quarterly, 2025-03-31) — Total Expenses: 37861315.00
CBAT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 192721548.00
CBAT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 168305711.00
CBAT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17219924.00
CBAT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -2864019.00
CBAT income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -45120.00
CBAT balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 831208.00
CBAT income_statement (quarterly, 2025-03-31) — Total Unusual Items: 58395.00
CBAT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 58395.00
CBAT balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 144206.00
CBAT balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 4066610.00
CBAT balance_sheet (quarterly, 2025-03-31) — Work In Process: 8412573.00
CBAT balance_sheet (quarterly, 2025-03-31) — Working Capital: -32342694.00
CBAT income_statement (quarterly, 2025-03-31) — Write Off: -58395.00
CBAT income_statement (quarterly, 2025-06-30) — +Operating Expense: 7990985.00
CBAT income_statement (quarterly, 2025-06-30) — +Total Revenue: 40524333.00
CBAT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 37244182.00
CBAT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 27479253.00
CBAT balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 172485.00
CBAT balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -57025055.00
CBAT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 247892318.00
CBAT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -2685681.00
CBAT cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 1645314.00
CBAT balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 16797055.00
CBAT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 89007924.00
CBAT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.03
CBAT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 47534703.00
CBAT balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 45456046.00
CBAT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -10719448.00
CBAT balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 3474542.00
CBAT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 90099.00
CBAT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 5679756.00
CBAT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 45734598.00
CBAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -30499878.00
CBAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -10711303.00
CBAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 13768485.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 2961115.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 3946165.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Inventory: -8667434.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -624443.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 6122.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Payable: 2961115.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 6907280.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 8873267.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Receivables: 6546861.00
CBAT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 13041653.00
CBAT cash_flow (quarterly, 2025-06-30) — Changes In Cash: -27442696.00
CBAT balance_sheet (quarterly, 2025-06-30) — Common Stock: 90099.00
CBAT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 118210911.00
CBAT balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 71635858.00
CBAT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 36061924.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 9878504.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Assets: 143447915.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1229323.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Debt: 34221675.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 35450998.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 19504880.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 19504880.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 199414338.00
CBAT balance_sheet (quarterly, 2025-06-30) — Current Provisions: 23312.00
CBAT cash_flow (quarterly, 2025-06-30) — Depreciation: 2292759.00
CBAT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2292759.00
CBAT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2292759.00
CBAT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 89007924.00
CBAT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.03
CBAT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -3072964.00
CBAT balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 1277572.00
CBAT income_statement (quarterly, 2025-06-30) — EBIT: -3528576.00
CBAT income_statement (quarterly, 2025-06-30) — EBITDA: -1235817.00
CBAT income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -21470.00
CBAT cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 21470.00
CBAT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1360215.00
CBAT cash_flow (quarterly, 2025-06-30) — End Cash Position: 21452222.00
CBAT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -30499878.00
CBAT balance_sheet (quarterly, 2025-06-30) — Finished Goods: 18555588.00
CBAT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 3049037.00
CBAT cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 28993.00
CBAT income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
CBAT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -9499446.00
CBAT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3350859.00
CBAT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 12380480.00
CBAT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 30164934.00
CBAT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 215803232.00
CBAT income_statement (quarterly, 2025-06-30) — Gross Profit: 4462409.00
CBAT cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
CBAT cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 186164.00
CBAT balance_sheet (quarterly, 2025-06-30) — Interest Payable: 76826.00
CBAT balance_sheet (quarterly, 2025-06-30) — Inventory: 37443143.00
CBAT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 157304302.00
CBAT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -10711303.00
CBAT balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 16797055.00
CBAT balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 18487694.00
CBAT cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 6399995.00
CBAT balance_sheet (quarterly, 2025-06-30) — Leases: 8345433.00
CBAT balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 33885284.00
CBAT balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2245219.00
CBAT balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 4871716.00
CBAT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 7116935.00
CBAT cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 6399995.00
CBAT cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1566832.00
CBAT balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1690639.00
CBAT balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 449122.00
CBAT balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 87114798.00
CBAT balance_sheet (quarterly, 2025-06-30) — Minority Interest: -2366772.00
CBAT income_statement (quarterly, 2025-06-30) — Minority Interests: 287434.00
CBAT balance_sheet (quarterly, 2025-06-30) — Net Debt: 33413635.00
CBAT income_statement (quarterly, 2025-06-30) — Net Income: -3072964.00
CBAT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -3072964.00
CBAT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3360398.00
CBAT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3072964.00
CBAT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3072964.00
CBAT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -3360398.00
CBAT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -3360398.00
CBAT income_statement (quarterly, 2025-06-30) — Net Interest Income: -163303.00
CBAT cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CBAT cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 4833163.00
CBAT cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 4833163.00
CBAT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -163303.00
CBAT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -34095921.00
CBAT cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 8145.00
CBAT balance_sheet (quarterly, 2025-06-30) — Net PPE: 158778177.00
CBAT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -10719448.00
CBAT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 105830431.00
CBAT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 10269732.00
CBAT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 10269732.00
CBAT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1235817.00
CBAT income_statement (quarterly, 2025-06-30) — Normalized Income: -3072964.00
CBAT balance_sheet (quarterly, 2025-06-30) — Notes Receivable: 7175921.00
CBAT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 13768485.00
CBAT cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 50463.00
CBAT income_statement (quarterly, 2025-06-30) — Operating Income: -3528576.00
CBAT income_statement (quarterly, 2025-06-30) — Operating Revenue: 40524333.00
CBAT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 88867313.00
CBAT balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 336391.00
CBAT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -9499446.00
CBAT balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 14101689.00
CBAT income_statement (quarterly, 2025-06-30) — Other Gand A: 3350859.00
CBAT income_statement (quarterly, 2025-06-30) — Other Income Expense: 331481.00
CBAT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 12380480.00
CBAT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 352951.00
CBAT balance_sheet (quarterly, 2025-06-30) — Other Payable: 95019313.00
CBAT balance_sheet (quarterly, 2025-06-30) — Other Properties: 3251097.00
CBAT balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1628843.00
CBAT balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 40054842.00
CBAT balance_sheet (quarterly, 2025-06-30) — Payables: 134556644.00
CBAT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 144435148.00
CBAT balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 4350978.00
CBAT income_statement (quarterly, 2025-06-30) — Pretax Income: -3360398.00
CBAT balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CBAT income_statement (quarterly, 2025-06-30) — Provision For Doubtful Accounts: 75871.00
CBAT cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 75871.00
CBAT cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
CBAT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -10719448.00
CBAT balance_sheet (quarterly, 2025-06-30) — Raw Materials: 8266528.00
CBAT balance_sheet (quarterly, 2025-06-30) — Receivables: 40146730.00
CBAT balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -213390.00
CBAT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 36061924.00
CBAT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2292759.00
CBAT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1566832.00
CBAT income_statement (quarterly, 2025-06-30) — Research And Development: 3613478.00
CBAT balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 15772466.00
CBAT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -129070019.00
CBAT income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 950777.00
CBAT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4301636.00
CBAT balance_sheet (quarterly, 2025-06-30) — Share Issued: 90099500.00
CBAT income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CBAT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 22823.00
CBAT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 118210911.00
CBAT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 105830431.00
CBAT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CBAT income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
CBAT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CBAT balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 3903618.00
CBAT balance_sheet (quarterly, 2025-06-30) — Total Assets: 333094266.00
CBAT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 123082627.00
CBAT balance_sheet (quarterly, 2025-06-30) — Total Debt: 42567933.00
CBAT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 115844139.00
CBAT income_statement (quarterly, 2025-06-30) — Total Expenses: 44052909.00
CBAT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 217250127.00
CBAT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 189646351.00
CBAT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 17835789.00
CBAT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3528576.00
CBAT income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 163303.00
CBAT balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1015577.00
CBAT income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CBAT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CBAT balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 1232187.00
CBAT balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 5303730.00
CBAT balance_sheet (quarterly, 2025-06-30) — Work In Process: 10621027.00
CBAT balance_sheet (quarterly, 2025-06-30) — Working Capital: -55966423.00
CBAT income_statement (quarterly, 2025-09-30) — +Operating Expense: 8909396.00
CBAT income_statement (quarterly, 2025-09-30) — +Total Revenue: 60923560.00
CBAT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 48938192.00
CBAT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 24429381.00
CBAT balance_sheet (quarterly, 2025-09-30) — Accrued Interest Receivable: 75268.00
CBAT balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -63054699.00
CBAT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 248487184.00
CBAT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2532012.00
CBAT cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 1167549.00
CBAT balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 16898724.00
CBAT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 89644226.00
CBAT income_statement (quarterly, 2025-09-30) — Basic EPS: 0.03
CBAT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 21452222.00
CBAT balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 45748897.00
CBAT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -8601129.00
CBAT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3328536.00
CBAT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 88646.00
CBAT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10476254.00
CBAT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 10476254.00
CBAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 34776759.00
CBAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -8440371.00
CBAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 14599484.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 19979232.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 2993954.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: -183851.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Inventory: 1835045.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -167784.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 998.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Payable: 19795381.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 22789335.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1944512.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Receivables: -12598185.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: -183851.00
CBAT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 9914897.00
CBAT cash_flow (quarterly, 2025-09-30) — Changes In Cash: 40935872.00
CBAT balance_sheet (quarterly, 2025-09-30) — Common Stock: 88646.00
CBAT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 121409257.00
CBAT cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -263111.00
CBAT balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 89458297.00
CBAT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 56047837.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 10283432.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Assets: 157693410.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1347803.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Debt: 29906369.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 31254172.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 19327602.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 19327602.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 228002695.00
CBAT balance_sheet (quarterly, 2025-09-30) — Current Provisions: 23453.00
CBAT cash_flow (quarterly, 2025-09-30) — Depreciation: 1534081.00
CBAT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1534081.00
CBAT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1534081.00
CBAT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 89661699.00
CBAT income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.03
CBAT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2650503.00
CBAT balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 1252580.00
CBAT income_statement (quarterly, 2025-09-30) — EBIT: -4033673.00
CBAT income_statement (quarterly, 2025-09-30) — EBITDA: -2499592.00
CBAT income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 147.00
CBAT cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -147.00
CBAT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 960577.00
CBAT cash_flow (quarterly, 2025-09-30) — End Cash Position: 63348671.00